{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:54:22Z","timestamp":1786766062990,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08272-1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:35:12Z","timestamp":1779384912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A pH-responsive miR-146a-loaded Gel\/MSN nanocarrier enhances anti-inflammatory efficacy in allergic rhinitis through pyroptosis suppression"],"prefix":"10.1186","volume":"24","author":[{"given":"Limei","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saike","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangkuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakui","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9789-1318","authenticated-orcid":false,"given":"Xicheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"10","key":"8272_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.2024.0530","volume":"331","author":"JA Bernstein","year":"2024","unstructured":"Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic rhinitis: a review. JAMA. 2024;331(10):866\u201377. https:\/\/doi.org\/10.1001\/jama.2024.0530.","journal-title":"JAMA"},{"key":"8272_CR2","doi-asserted-by":"publisher","unstructured":"Savour\u00e9 M, Bousquet J, Jaakkola JJK, Jaakkola MS, Jacquemin B, Nadif R. Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution. Clin Transl All. 2022;12(3):e12130. https:\/\/doi.org\/10.1002\/clt2.12130.","DOI":"10.1002\/clt2.12130"},{"issue":"11","key":"8272_CR3","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1111\/all.15454","volume":"77","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lan F, Zhang L. Update on pathomechanisms and treatments in allergic rhinitis. Allergy. 2022;77(11):3309\u201319. https:\/\/doi.org\/10.1111\/all.15454.","journal-title":"Allergy"},{"issue":"1","key":"8272_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8722-5-13","volume":"5","author":"C Labbaye","year":"2012","unstructured":"Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol. 2012;5(1):13. https:\/\/doi.org\/10.1186\/1756-8722-5-13.","journal-title":"J Hematol Oncol"},{"key":"8272_CR5","doi-asserted-by":"publisher","first-page":"101374","DOI":"10.1016\/j.arr.2021.101374","volume":"70","author":"F Olivieri","year":"2021","unstructured":"Olivieri F, Prattichizzo F, Giuliani A, Matacchione G, Rippo MR, Sabbatinelli J, et al. miR-21 and miR-146a: the microRNAs of inflammaging and age-related diseases. Ageing Res Rev. 2021;70:101374. https:\/\/doi.org\/10.1016\/j.arr.2021.101374.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"8272_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood.2019002045","volume":"135","author":"Y-L Su","year":"2020","unstructured":"Su Y-L, Wang X, Mann M, Adamus TP, Wang D, Moreira DF, et al. Myeloid cell\u2013targeted miR-146a mimic inhibits NF-\u03baB\u2013driven inflammation and leukemia progression in vivo. Blood. 2020;135(3):167\u201380. https:\/\/doi.org\/10.1182\/blood.2019002045.","journal-title":"Blood"},{"issue":"1","key":"8272_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12951-024-02631-0","volume":"22","author":"W-T Meng","year":"2024","unstructured":"Meng W-T, Zhu J, Wang Y-C, Shao C-L, Li X-Y, Lu P-P, et al. Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-\u03baB signaling pathway after myocardial ischemia-reperfusion injury. J Nanobiotechnol. 2024;22(1):382. https:\/\/doi.org\/10.1186\/s12951-024-02631-0.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"8272_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/all.15163","volume":"77","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang Y, Guo J, Cui L, Yang L, Li Y, et al. miR-146a enhances regulatory T-cell differentiation and function in allergic rhinitis by targeting STAT5b. Allergy. 2022;77(2):550\u201358. https:\/\/doi.org\/10.1111\/all.15163.","journal-title":"Allergy"},{"key":"8272_CR9","doi-asserted-by":"publisher","first-page":"154516","DOI":"10.1016\/j.phymed.2022.154516","volume":"108","author":"H Li","year":"2023","unstructured":"Li H, Wang Y, Han X. ESP-B4 promotes nasal epithelial cell-derived extracellular vesicles containing miR-146a-5p to modulate Smad3\/GATA-3 thus relieving allergic rhinitis: ESP-B4\/miR-146a-5p in AR. Phytomedicine. 2023;108:154516. https:\/\/doi.org\/10.1016\/j.phymed.2022.154516.","journal-title":"Phytomedicine"},{"issue":"1","key":"8272_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08820139.2015.1085390","volume":"45","author":"H-J Liu","year":"2016","unstructured":"Liu H-J, Zhang A-F, Zhao N, Li X-Z. Role of miR-146a in enforcing effect of specific immunotherapy on allergic rhinitis. Immunol Invest. 2016;45(1):1\u201310. https:\/\/doi.org\/10.3109\/08820139.2015.1085390.","journal-title":"Immunol Invest"},{"key":"8272_CR11","doi-asserted-by":"publisher","first-page":"138145","DOI":"10.1016\/j.jhazmat.2025.138145","volume":"492","author":"J Yuan","year":"2025","unstructured":"Yuan J, Liao Z, Zhu X, Zhu Y, Wu S, Guo L, et al. PM2.5 exacerbates nasal epithelial barrier dysfunction in allergic rhinitis by inducing NLRP3-mediated pyroptosis via the AhR\/CYP1A1\/ROS axis. J Educ Chang Hazard Mater. 2025;492:138145. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.138145.","journal-title":"J Educ Chang Hazard Mater"},{"key":"8272_CR12","doi-asserted-by":"publisher","first-page":"112998","DOI":"10.1016\/j.ecoenv.2021.112998","volume":"228","author":"J Li","year":"2021","unstructured":"Li J, Zhang Y, Zhang L, An Z, Song J, Wang C, et al. Fine particulate matter exposure exacerbated nasal mucosal damage in allergic rhinitis mice via NLRP3 mediated pyroptosis. Ecotox Environ Safe. 2021;228:112998. https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112998.","journal-title":"Ecotox Environ Safe"},{"issue":"1","key":"8272_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12964-023-01309-8","volume":"21","author":"Y-L Qiao","year":"2023","unstructured":"Qiao Y-L, Zhu M-W, Xu S, Jiao W-E, Ni H-F, Tao Z-Z, et al. Allergen-induced CD11c + dendritic cell pyroptosis aggravates allergic rhinitis. Cell Commun Signal. 2023;21(1):281. https:\/\/doi.org\/10.1186\/s12964-023-01309-8.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"8272_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","volume":"35","author":"P Broz","year":"2025","unstructured":"Broz P. Pyroptosis: molecular mechanisms and roles in disease. Cell Res. 2025;35(5):334\u201344. https:\/\/doi.org\/10.1038\/s41422-025-01107-6.","journal-title":"Cell Res"},{"issue":"1","key":"8272_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11064-022-03719-5","volume":"48","author":"D Zhang","year":"2023","unstructured":"Zhang D, Mao F, Wang S, Wu H, Wang S, Liao Y. Role of transcription factor Nrf2 in pyroptosis in spinal cord injury by regulating GSDMD. Neurochem Res. 2023;48(1):172\u201387. https:\/\/doi.org\/10.1007\/s11064-022-03719-5.","journal-title":"Neurochem Res"},{"issue":"7","key":"8272_CR16","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3390\/ijms22073384","volume":"22","author":"M Zajac","year":"2021","unstructured":"Zajac M, Dreano E, Edwards A, Planelles G, Sermet-Gaudelus I. Airway surface liquid pH regulation in airway epithelium current understandings and gaps in knowledge. IJMS. 2021;22(7):3384. https:\/\/doi.org\/10.3390\/ijms22073384.","journal-title":"IJMS"},{"issue":"Pt 3","key":"8272_CR17","doi-asserted-by":"publisher","first-page":"145463","DOI":"10.1016\/j.ijbiomac.2025.145463","volume":"319","author":"M Alahverdi","year":"2025","unstructured":"Alahverdi M, Dadmehr M, Sahebkar A. Nanocarriers for microRNA delivery: a review of applied platforms and perspectives. Int J Biol Macromolecules. 2025;319(Pt 3):145463. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145463.","journal-title":"Int J Biol Macromolecules"},{"issue":"32","key":"8272_CR18","doi-asserted-by":"publisher","first-page":"9272","DOI":"10.1002\/anie.201602188","volume":"55","author":"C Yu","year":"2016","unstructured":"Yu C, Qian L, Ge J, Fu J, Yuan P, Yao SCL, et al. Cell-penetrating Poly(disulfide) assisted intracellular delivery of Mesoporous silica nanoparticles for inhibition of miR-21 function and detection of subsequent therapeutic effects. Angew Chem Int Ed Engl. 2016;55(32):9272\u201376. https:\/\/doi.org\/10.1002\/anie.201602188.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"8272_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","volume":"142","author":"L-F Lu","year":"2010","unstructured":"Lu L-F, Boldin MP, Chaudhry A, Lin L-L, Taganov KD, Hanada T, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010;142(6):914\u201329. https:\/\/doi.org\/10.1016\/j.cell.2010.08.012.","journal-title":"Cell"},{"issue":"1","key":"8272_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","volume":"44","author":"MTD Martino","year":"2025","unstructured":"Martino MTD, Tagliaferri P, Tassone P. MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res. 2025;44(1):126. https:\/\/doi.org\/10.1186\/s13046-025-03391-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"8272_CR21","doi-asserted-by":"publisher","unstructured":"Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022, 2;2(1). https:\/\/doi.org\/10.1038\/s43586-022-00104-y.","DOI":"10.1038\/s43586-022-00104-y"},{"key":"8272_CR22","doi-asserted-by":"publisher","first-page":"12343","DOI":"10.2147\/IJN.S497480","volume":"19","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Cui L, Lu H, Liu Z, Zhai Z, Wang H, et al. Nose to brain: exploring the progress of intranasal delivery of solid Lipid nanoparticles and nanostructured Lipid carriers. IJN. 2024;19:12343\u201368. https:\/\/doi.org\/10.2147\/IJN.S497480.","journal-title":"IJN"},{"issue":"1","key":"8272_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12016-024-09019-w","volume":"68","author":"L Cui","year":"2025","unstructured":"Cui L, Yang Y, Hao Y, Zhao H, Zhang Y, Wu T, et al. Nanotechnology-based therapeutics for airway inflammatory diseases. Clinic Rev Allerg Immunol. 2025;68(1):12. https:\/\/doi.org\/10.1007\/s12016-024-09019-w.","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"10","key":"8272_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/pharmaceutics12100907","volume":"12","author":"Y Su","year":"2020","unstructured":"Su Y, Sun B, Gao X, Liu S, Hao R, Han B. Chitosan hydrogel doped with PEG-PLA nanoparticles for the local delivery of miRNA-146a to treat allergic rhinitis. Pharmaceutics. 2020;12(10):907. https:\/\/doi.org\/10.3390\/pharmaceutics12100907.","journal-title":"Pharmaceutics"},{"key":"8272_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2019.01.002","volume":"136","author":"A Mohamed","year":"2019","unstructured":"Mohamed A, Kunda NK, Ross K, Hutcheon GA, Saleem IY. Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). Eur J Criminol Pharm Biopharmaceutics. 2019;136:1\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.002.","journal-title":"Eur J Criminol Pharm Biopharmaceutics"},{"issue":"1","key":"8272_CR26","doi-asserted-by":"publisher","first-page":"1723260","DOI":"10.1080\/20013078.2020.1723260","volume":"9","author":"S-B Fang","year":"2020","unstructured":"Fang S-B, Zhang H-Y, Wang C, He B-X, Liu X-Q, Meng X-C, et al. Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p. J Extracell Vesicle. 2020;9(1):1723260. https:\/\/doi.org\/10.1080\/20013078.2020.1723260.","journal-title":"J Extracell Vesicle"},{"issue":"2","key":"8272_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1039\/D2QM01009G","volume":"7","author":"M De, Santo Ag","year":"2023","unstructured":"De, Santo Ag M, Giovinazzo A, Fava M, Mazzotta IE, De Napoli IE, Greco M, et al. Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration. Mater Chem Front. 2023;7(2):216. https:\/\/doi.org\/10.1039\/D2QM01009G.","journal-title":"Mater Chem Front"},{"key":"8272_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","volume":"348","author":"H Ding","year":"2022","unstructured":"Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X, et al. Preparation and application of pH-responsive drug delivery systems. J Control Release. 2022;348:206\u201338. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.056.","journal-title":"J Control Release"},{"issue":"8","key":"8272_CR29","doi-asserted-by":"publisher","first-page":"2400113","DOI":"10.1002\/smsc.202400113","volume":"4","author":"M Puzzo","year":"2024","unstructured":"Puzzo M, De Santo M, Morelli C, Leggio A, Pasqua L. The advent of molecular targeted therapies against cancer. Toward Multi-targeting drugs through materials engineering: a possible future scenario. Small Sci. 2024;4(8):2400113. https:\/\/doi.org\/10.1002\/smsc.202400113.","journal-title":"Small Sci"},{"key":"8272_CR30","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.mtbio.2022.100472","volume":"17","author":"E Mazzotta","year":"2022","unstructured":"Mazzotta E, De Santo M, Lombardo D, Leggio A, Pasqua L. Mesoporous silicas in materials engineering: nanodevices for bionanotechnologies. Mater Today Bio. 2022;17:100472. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100472.","journal-title":"Mater Today Bio"},{"issue":"6","key":"8272_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/pharmaceutics12060505","volume":"12","author":"L Haddick","year":"2020","unstructured":"Haddick L, Zhang W, Reinhard S, M\u00f6ller K, Engelke H, Wagner E, et al. Particle-size-dependent delivery of antitumoral miRNA using targeted Mesoporous silica nanoparticles. Pharmaceutics. 2020;12(6):505. https:\/\/doi.org\/10.3390\/pharmaceutics12060505.","journal-title":"Pharmaceutics"},{"issue":"13","key":"8272_CR32","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.3390\/ma17133352","volume":"17","author":"A Grisolia","year":"2024","unstructured":"Grisolia A, De Santo M, Curcio M, Cavallaro PA, Morelli C, Leggio A, et al. Engineered Mesoporous silica-based nanoparticles: characterization of surface properties. Mater (Basel). 2024;17(13):3352. https:\/\/doi.org\/10.3390\/ma17133352.","journal-title":"Mater (Basel)"},{"issue":"7","key":"8272_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","volume":"26","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X. Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol. 2025;26(7):501\u201321. https:\/\/doi.org\/10.1038\/s41580-025-00837-0.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8272_CR34","doi-asserted-by":"publisher","unstructured":"Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G. The NLRP3 Inflammasome: mechanisms of activation, regulation, and therapeutic opportunities. MedComm (2020). 2026;7(3):e70660. https:\/\/doi.org\/10.1002\/mco2.70660.","DOI":"10.1002\/mco2.70660"},{"key":"8272_CR35","doi-asserted-by":"publisher","unstructured":"Kim H-Y, Cho J, Park MK, Min D-H, Hwang JG, Won C. A first-in-human Phase 1 study to evaluate the safety and tolerability of LEM-S401, a novel siRNA-DegradaBALL drug targeting CTGF in healthy adults. Clin Transl Sci. 2025;18(4):e70207. https:\/\/doi.org\/10.1111\/cts.70207.","DOI":"10.1111\/cts.70207"},{"issue":"2","key":"8272_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/2211738511666230106151403","volume":"11","author":"F Mirzaali","year":"2023","unstructured":"Mirzaali F, Dizaj SM, Shahi S, Memar MY, Parnia F. The antibacterial effect of tetracycline-loaded Mesoporous silica nanoparticles in the gingival fluid at implant-abutment junction: a randomized clinical trial study. PNT. 2023;11(2):208\u201316. https:\/\/doi.org\/10.2174\/2211738511666230106151403.","journal-title":"PNT"},{"key":"8272_CR37","doi-asserted-by":"publisher","unstructured":"Huq TB, Anil Kumar Jeeja P, Dam SK, Das SS, Vivero-Escoto JL. Recent applications of Mesoporous silica nanoparticles in gene therapy. Adv Healthcare Mater. 2025;14(26):e2404781. https:\/\/doi.org\/10.1002\/adhm.202404781.","DOI":"10.1002\/adhm.202404781"},{"key":"8272_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","volume":"351","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release. 2022;351:923\u201340. https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.005.","journal-title":"J Control Release"},{"key":"8272_CR39","doi-asserted-by":"publisher","first-page":"115115","DOI":"10.1016\/j.addr.2023.115115","volume":"203","author":"TI Janjua","year":"2023","unstructured":"Janjua TI, Cao Y, Kleitz F, Linden M, Yu C, Popat A. Silica nanoparticles: a review of their safety and current strategies to overcome biological barriers. Adv Drug Deliv Rev. 2023;203:115115. https:\/\/doi.org\/10.1016\/j.addr.2023.115115.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08272-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:44:37Z","timestamp":1784180677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08272-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8272"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08272-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Peripheral blood mononuclear cells (PBMCs) were obtained from clinically confirmed AR patients and age\/sex-matched healthy controls following written informed consent. All procedures were approved by the Ethics Committee of Yantai Yuhuangding Hospital Affiliated to Qingdao University (Approval No: 2022\u2013419), in compliance with the Declaration of Helsinki. Male C57BL\/6J mice and Sprague-Dawley (SD) rats (6\u20138\u2009weeks, SPF-grade) were procured from Jinan Pengyue Experimental Animal Breeding Co., Ltd. (License No: SCXK[Lu]2023\u20130002). Animals were housed in specific pathogen-free SPF conditions at the Central Laboratory of Yantai Yuhuangding Hospital, with environmental parameters maintained according to Chinese National Standards GB 14,925\u20132010 (environmental requirements) and GB 14,924.3\u20132010 (nutritional standards).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have approved the manuscript and agree with its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"918"}}